"beta-Lactam Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.
| Descriptor ID |
D018440
|
| MeSH Number(s) |
G06.099.225.500 G06.225.347.500 G07.690.773.984.269.347.500
|
| Concept/Terms |
beta-Lactam Resistance- beta-Lactam Resistance
- beta Lactam Resistance
- beta-Lactamase Resistant
- Resistant, beta-Lactamase
- beta Lactamase Resistant
- beta-Lactam Resistant
- beta Lactam Resistant
- beta-Lactamase Resistance
- Resistance, beta-Lactamase
- beta Lactamase Resistance
|
Below are MeSH descriptors whose meaning is more general than "beta-Lactam Resistance".
Below are MeSH descriptors whose meaning is more specific than "beta-Lactam Resistance".
This graph shows the total number of publications written about "beta-Lactam Resistance" by people in this website by year, and whether "beta-Lactam Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "beta-Lactam Resistance" by people in Profiles.
-
Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012. J Pediatric Infect Dis Soc. 2017 Nov 24; 6(4):352-359.
-
Rapid Identification of Five Classes of Carbapenem Resistance Genes Directly from Rectal Swabs by Use of the Xpert Carba-R Assay. J Clin Microbiol. 2017 07; 55(7):2268-2275.
-
Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control. J Hosp Infect. 2016 Sep; 94(1):60-4.
-
Measuring Carbapenem-Resistant Enterobacteriaceae in the United States: A Critical Step for Control. JAMA. 2015 Oct 13; 314(14):1455-6.
-
Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012 Sep; 55(6):852-9.
-
Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010 Apr; 31(4):341-7.
-
Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report. Ann Pharmacother. 2008 Feb; 42(2):207-12.
-
Faropenem medoxomil. Ann Pharmacother. 2008 Jan; 42(1):80-90.
-
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004 Jul 01; 39(1):31-7.
-
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med. 2004 Jan 06; 140(1):26-32.